SND1 and cancer: Extensive research also supports the conclusion that SND1 is an oncoprotein in a variety of cancers involving multiple processes (Jariwala et al., 2017; Xin et al., 2019) and that it also acts as an essential effector in promoting EMT in cancer (Xin et al., 2019; He et al., 2020).